Lidenzal 2%
- Product NDC
- 70529-002
- 11-digit product format
- 705290002
- Labeler code
- 70529
- Product ID
- 70529-002_12e0a7ee-6b4b-4ca1-b906-cb45020ebc2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- LIDOCAINE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INFILTRATION; PERINEURAL
- Labeler
- IT3 Medical LLC
- Application
- ANDA088327
- Marketing category
- ANDA
- Marketing start
- 2017-03-01
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70529-002-01 | Lidenzal 2% | 1 in 1 PACKAGE | INJECTION, SOLUTION | 1 | | 3 |
| 70529-002-01 | Lidenzal 2% | 50 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 50 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70529-002 | LIDENZAL 2% (LIDOCAINE HYDROCHLORIDE) INJECTION, SOLUTION [IT3 MEDICAL LLC] | 3 | Legacy NDC, 2 package rows | 20220302_c9d8141b-07f8-462a-b685-11dacaf86e9c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70529-002-01 | 70529000201 | 1 VIAL, MULTI-DOSE in 1 PACKAGE (70529-002-01) > 50 mL in 1 VIAL, MULTI-DOSE | 2017-03-01 | 0000-00-00 | No | No | Current |